Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer by Seini Moimoi | Mar 4, 2021 | Portfolio News
Orbus Therapeutics Announces Positive Outcome of Pre-Planned Interim Futility Analysis for Phase 3 Eflornithine STELLAR Study by Seini Moimoi | Mar 2, 2021 | Portfolio News
Orbus Therapeutics Announces Positive Outcome of Pre-Planned Interim Futility Analysis for Phase 3 Eflornithine STELLAR Study by Seini Moimoi | Mar 2, 2021 | Portfolio News
Axonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device by Seini Moimoi | Mar 2, 2021 | Portfolio News
Axonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device by Seini Moimoi | Mar 2, 2021 | Portfolio News
